Quick navigation menu :

  1. Go to the content
  2. Go to the main sections menu
  3. Go to the search engine
  4. Go to the languages menu
  5. Go to the help menu
  6. Go to the modules
  7. Go to the shortcuts list

Help menu :

  1. Sanofi Worldwide |
  2. Canadian Web Sites |
  3. Global Business Websites |
  4. Contact us |
  5. Sitemap |
  6. Help
  1. RSS
  2. Font size

    Reduce font size Increase font size  

Media Room

Contact us

Sanofi Canada

2905 Place Louis-R.-Renaud
Laval, Quebec, H7V 0A3

Media inquiries

Toll-free: 1-877-904-2667

Catherine Cunningham

Manager, Corporate and
Brand Communications

General inquiries


Press Releases

Archives: Search / 2017 / 2016 / 2015 / 2014 / 2013 / 2012 / 2011


May 12, 2017

The Connecting Nurses Patient Centricity program is proud to announce that Guillaume Fontaine, a Montreal-based graduate student and registered nurse, will be a recipient of the 2017 Global...

Apr 7, 2017

Laval, Quebec (April 7, 2017) — Sanofi Canada announces, all new and existing Canadian patients prescribed Renagel® or Renvela®, will have access to RenassistPLUS, a patient support and...

Jan 27, 2017
Sanofi Canada Recognized as One of Canada’s Top R&D Investors

Montreal, Quebec – January 26, 2017 – Sanofi Canada is pleased to announce that it ranks among Canada’s Top 100 Corporate Research and Development (R&D) Spenders, according to a new report...

May 26, 2016

- FDA decisions on the investigational fixed-ratio combination of basal insulin glargine 100 Units/mL and GLP-1 receptor agonist lixisenatide and investigational lixisenatide anticipated in Q3 2016 -

May 24, 2016

As 8 in 10 Canadian GPs identify the need for new cholesterol treatment options, Canadian Patients now have accessto PRALUENT™ MONTREAL, May 24, 2016 /CNW Telbec/ - Sanofi Canada is pleased to...

May 9, 2016

Iveta Demirova, 16, student at New Westminster Secondary School in British Columbia, Recognized for Novel HIV-1 Treatment OTTAWA, May 9, 2016 /CNW Telbec/ - Iveta Demirova from New Westminster...

Feb 23, 2016

Sanofi (EURONEXT : SAN and NYSE : SNY) announced today that the License and Development Agreement between Sanofi and kaléo, formerly Intelliject Inc., the developer of Auvi-Q® and Allerject®...

Feb 4, 2016

Montreal, Quebec – February 4, 2016 – Sanofi Canada is pleased to announce that it has once again been named one of Montreal’s Top Employers, a designation that recognizes its consistent...

Dec 2, 2015

Following the October 28, 2015 voluntary recall by Sanofi-aventis Canada Inc. (Sanofi Canada) of all lots of Allerject® epinephrine auto-injectors of both the 0.15mg/0.15mL and 0.30mg/0.3mL...

Nov 9, 2015

Sanofi Canada is proud to announce that it has been named one of Canada's Top 100 Employers by a prestigious annual competition that recognizes the nation's best places to work. The competition is...


Corporate information